ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 114 filers reported holding ESPERION THERAPEUTICS INC NE in Q4 2015. The put-call ratio across all filers is 1.12 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $444,000 | +2511.8% | 16,625 | -73.6% | 0.67% | +2206.9% |
| Q2 2017 | $17,000 | -98.0% | 63,000 | -45.2% | 0.03% | -97.4% |
| Q1 2017 | $839,000 | +129.9% | 114,934 | +293.7% | 1.10% | +163.5% |
| Q4 2016 | $365,000 | -20.0% | 29,193 | -78.2% | 0.42% | +15.7% |
| Q3 2016 | $456,000 | -54.1% | 133,800 | -19.5% | 0.36% | -57.5% |
| Q2 2016 | $993,000 | +53.7% | 166,299 | +34.7% | 0.85% | +25.8% |
| Q1 2016 | $646,000 | +136.6% | 123,496 | +517.5% | 0.68% | +235.1% |
| Q4 2015 | $273,000 | – | 20,000 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 2,818,835 | $59,618,000 | 21.09% |
| Bellevue Group AG | 4,519,164 | $95,580,000 | 0.93% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 1,713,176 | $36,234,000 | 0.84% |
| Rhenman & Partners Asset Management AB | 572,267 | $12,103,000 | 0.82% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 64,434 | $1,363,000 | 0.45% |
| Boxer Capital, LLC | 500,000 | $10,575,000 | 0.37% |
| EMC Capital Management | 27,566 | $583,000 | 0.33% |
| WASATCH ADVISORS LP | 3,766,935 | $79,671,000 | 0.32% |
| Avidity Partners Management LP | 400,000 | $8,460,000 | 0.23% |
| Cinctive Capital Management LP | 186,170 | $3,937,000 | 0.18% |